Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
91 Cards in this Set
- Front
- Back
The native microbial forms that an individual harbors.
|
Normal (Resident) Flora
|
|
Belonging or native to.
|
Indigenous
|
|
The entry, establishment, and multiplication of pathogenic organisms within a host.
|
Infection
|
|
Any agent, usually a virus, bacterium, fungus, protozoan, or helminth, that causes disease.
|
Pathogen
|
|
The state of damage or toxicity in the body caused by an infectious agent.
|
Infectious Disease
|
|
In normal flora, the assortment of superficial microbes whose numbers and types vary depending upon recent exposure. The deeper-lying residents constitute a more stable population.
|
Transient
|
|
The deeper, more stable, microflora that inhabit the skin and exposed mucous membranes, as opposed to the superficial, variable, transient population.
|
Residents
|
|
A property of microorganisms which enables one microorganism to kill, injure, or inhibit the growth of a different microorganism.
|
Microbial Antagonism
|
|
Originating or produced within an organism or one of its parts.
|
Endogenous
|
|
The cavity within a tubular organ.
|
Lumen
|
|
A collective term that includes normal enteric bacteria that are gram-negative and lactose-fermenting.
|
Coliforms
|
|
A microbe or mixture of microbes that may be used to balance the normal flora and prevent infections.
|
Probiotics
|
|
Are capable of causing disease in healthy persons with normal immune defenses. Examples: influenza virus, plague bacillus, and malarial protozoan.
|
True pathogens (Primary pathogens)
|
|
A situation where ordinarily nonpathogenic or weakly pathogenic microbes cause disease in an immunologically compromised host.
|
Opportunistic pathogens (opportunistic infection)
|
|
A product of microbes such as an enzyme or toxin that increases the invasiveness or pathogenicity.
|
Virulence Factor
|
|
Characteristics route of entry for an infectious agent; typically a cutaneous or membranous route.
|
Portal of Entry
|
|
Originating outside the body.
|
Exogenous
|
|
Infections resulting from pathogens that enter the body via sexual intercourse or intimate, direct contact.
|
Sexually transmitted disease (STD)
|
|
Acronym for common infections of the fetus and neonate. STORCH stands for Syphilis, Toxoplasmosis, Other disease (hepatitis B, AIDS, and chlamydiosis), Rubella, Cytomegalovirus and Herpes simplex virus.
|
Storch
|
|
The estimated number of microbial cells or units required to establish an infection.
|
Infectious dose
|
|
The process by which microbes gain a more stable foothold at the portal of entry; often involves a specific interaction between the molecules on the microbial surface and the receptors on the host cell.
|
Adhesion
|
|
A type of endocytosis in which the cell membrane actively engulfs large particles or cells into vesicles. A phagocyte is a cell specialized for doing this.
|
Phagocytosis and Phagocytes
|
|
A heat-liable substances formed by some pyogenic cocci that impairs and sometimes lyses leukocytes.
|
Leukocidins
|
|
An extracellular enzyme chiefly for hydrolysis of nutrient macromolecules that are otherwise impervious to the cell membrane. It functions in saprobic decomposition of organic debris and can be a factor in invasiveness of pathogens.
|
Exoenzymes
|
|
A specific chemical product of microbes, plants, and some animals that is poisonous to other organisms.
|
Toxin
|
|
The tendency for a pathogen to produce toxins. It is an important factor in bacterial virulence.
|
Toxigenicity
|
|
Disease whose adverse effects are primarily due to the production and release of toxins.
|
Toxinoses
|
|
An abnormality associated with certain infectious diseases. Toxemia is caused by toxins or other noxious substances released by microorganisms circulating in the blood.
|
Toxemias
|
|
Poisoning that results from the introduction of a toxin into body tissues through ingestion or injection.
|
Intoxications
|
|
A toxin (usually protein) that is secreted and acts upon a specific cellular target. Examples: botulin, tetanospasmin, diphtheria toxin, and erythrogenic toxin.
|
Exotoxin
|
|
A bacterial intracellular toxin that is not ordinarily released (as is exotoxin). Endotoxin is composed of a phospholipid-polysaccharide complex that is an integral part of gram-negative bacterial cell walls.
|
Endotoxin
Endotoxin is composed of a phospholipid-polysaccharide complex that is an integral part of gram-negative bacterial cell walls. Endotoxins can cause severe shock and fever. |
|
Any biological agent that is capable of destroying red blood cells and causing the release of hemoglobin. Many bacterial pathogens produce exotoxins that act as hymolysins.
|
Hemolysins
|
|
Hemolysin
|
Hemolyze
|
|
The period from the initial contact with an infectious agent to the appearance of the first symptoms.
|
Incubation Period
|
|
A short period of mild symptoms occurring at the end of the period of incubation. It indicates the onset of an infection.
|
Prodromium
|
|
A combined microbial toxin with part B that binds to the cell and part A that disrupts cell function.
|
A-B Toxin
|
|
The period during a clinical infection when the infectious agent multiplies at high levels, exhibits its greatest toxicity and becomes well established in the target tissues.
|
Period of Invasion
|
|
Recovery; the period between the end of a disease and the complete restoration of health in a patient.
|
Convalescence
|
|
Occurring throughout the body; said of infections that invade many compartments and organs via the circulation.
|
Systemic (Infection)
|
|
Occurs when an infectious agent breaks loose from a localized infection and is carried by the circulation to other tissues.
|
Focal Infection
|
|
Occurs when several different pathogens interact simultaneously to produce an infection. Also called a synergistic infection.
|
Mixed Infection
|
|
Diseases that may result of biofilm formation at the site of infection.
|
Polymicrobial
|
|
An initial infection in a previously healthy individual that is later complicated by an additional (secondary) infection.
|
Primary Infection
|
|
Characterized by rapid onset and short duration.
|
Acute
|
|
Any process or disease that persists over a long duration.
|
Chronic
|
|
Any abnormality uncovered upon physical diagnosis that indicates the presence of disease. A sign is an objective assessment of disease, as opposed to a symptom, which is the subjective assessment perceived by the patient.
|
Sign
|
|
The subjective evidence of infection and disease as perceived by the patient.
|
Symptom
|
|
The collection of signs and symptoms that, taken together, pain a portrait of the disease.
|
Syndrome
|
|
A natural, nonspecific response to tissue injury that protects the host from further damage. It stimulates immune reactivity and blocks the spread of an infectious agent.
|
Inflammation
|
|
The accumulation of excess fluid in cells, tissues, or serous cavities. Also called swelling.
|
Edema
|
|
A solid mass or nodule of inflammatory tissue containing modified macrophages and lymphocytes. Usually a chronic pathologic process of diseases such as tuberculosis or syphilis.
|
Granulomas
|
|
An inflamed, fibrous lesion enclosing a core of pus.
|
Abscesses
|
|
Inflammation of one or more lymph nodes. Also called lymphadenopathy.
|
Lymphadenitis
|
|
A wound, injury, or some other pathologic change in tissues.
|
Lesion
|
|
An abnormally large number of leukocytes in the blood, which can be indicative of acute infection.
|
Leukocytosis
|
|
A lower-than-normal leukocyte count in the blood, which can be indicative of blood infection or disease.
|
Leukopenia
|
|
Systemic infection associated with microorganisms multiplying in circulating blood.
|
Septicemia
|
|
The presence of viable bacteria in circulating blood.
|
Bacteremia
|
|
The presence of a virus in the bloodstream.
|
Viremia
|
|
An infection that produces no noticeable symptoms even though the microbe is active in the host tissue.
|
Asymptomatic
|
|
A period of inapparent manifestations that occurs before symptoms and signs of disease appear.
|
Subclinical
|
|
Characteristic route through which a pathogen departs from the host organism.
|
Portal of Exit
|
|
The state of being inactive and not multiplying. Example: a latent virus or latent infection.
|
Latency
|
|
A morbid complication that follows a disease.
|
Sequelae
|
|
In disease communication, the natural host or habitat of a pathogen.
|
Reservoir
|
|
The person or item from which an infection is immediately acquired.
|
Source
|
|
A person who harbors infections and inconspicuously spreads them to others. Also, a chemical agent that can accept an atom, chemical radical, or subatomic particle from one compound and pass it on to another.
|
Carrier
|
|
A person with an inapparent infection who shows no symptoms of being infected yet is able to pass the disease agent on to others.
|
Asymptomatic Carrier
|
|
Persons who mechanically transfer a pathogen without ever being infected by it, for example, a health care worker who doesn't wash his/her hands adequately between patients.
|
Passive Carrier
|
|
An animal that not only transports an infectious agent but plays a role in the life cycle of the pathogen, serving as a site in which it can multiply or complete its life cycle. It is usually an alternate host to the pathogen.
|
Biological Vector
|
|
An animal that transports an infectious agent but is not infected by it, such as houseflies whose feet become contaminated with feces.
|
Mechanical Vectors
|
|
An infectious disease indigenous to animals that humans can acquire through direct or indirect contact with infected animals.
|
Zoonosis
|
|
Capable of being transmitted from one individual to another.
|
Communicable Infection
|
|
An impurity; any undesirable material or organism. A culture into which unknown microbes have been introduced is contaminated.
|
Contagious
|
|
An infectious disease that does not arrive through transmission of an infectious agent from host to host.
|
Noncommunicable
|
|
An inanimate material (solid object, liquid, or air) that serves as a transmission agent for pathogens.
|
Vehicle
|
|
Virtually any inanimate object an infected individual has contact with that can serve as a vehicle for the spread of disease.
|
Fomite
|
|
The dried residue of fine droplets produced by mucus and saliva sprayed while sneezing and coughing. Droplet nuclei are less than 5 micrometers in diameter (large enough to bear a single bacterium and small enough to remain airborne for a long time) and can be carried by air currents. Droplet nuclei are drawn deep into the air passages.
|
Droplet Nuclei
|
|
Airborne suspensions of fine dust or moisture particles airborne that contain live pathogens.
|
Aerosols
|
|
An infection not present upon admission to a hospital but incurred while being treated there.
|
Nosocomial Infections
|
|
Centers for Disease Control and prevention guidelines for health care workers regarding the prevention of disease transmission when handling patients and body substances.
|
Universal Precautions
|
|
Those diseases that must be reported to health authorities by law.
|
Reportable Disease
|
|
Any deviation from health, as when the effects of microbial infection damage or disrupt tissues and organs.
|
Diseases
|
|
The total cumulative number of cases of a disease in a certain area and time period.
|
Prevalence
|
|
In epidemiology, the number of new cases of a disease occurring during a period.
|
Incidence
|
|
Total number of deaths in a population attributable to a particular disease.
|
Mortality Rate
|
|
A diseased condition.
|
Morbidity
|
|
A native disease that prevails continuously in a geographic region.
|
Endemic Disease
|
|
Description of a disease which exhibits new cases at irregular intervals in unpredictable geographic locales.
|
Sporadic
|
|
A sudden and simultaneous outbreak or increase in the number of cases of disease in a community.
|
Epidemic
|
|
A disease afflicting an increased proportion of the population over a wide geographic area (often worldwide).
|
Pandemic
|